SPINEVISION SAS è una società privata di tecnologia spinale integrata focalizzata sullo sviluppo e sulla commercializzazione di impianti e strumentazione per il trattamento della colonna vertebrale.
CHI SIAMO
INVESTITORE
Norgine Ventures
Presidente : Peter Martin
www.norgineventures.com
LA PAROLA DEL CEO
SPINEVISION SAS è un’azienda che opera nel settore della colonna vertebrale e che mira a far progredire la chirurgia attraverso soluzioni innovative ispirate dai chirurghi e incentrate sul paziente. L’utilizzo delle più recenti evidenze scientifiche, l’ingegneria di alta qualità e le strutture produttive all’avanguardia consentono di ottenere risultati più significativi per i pazienti e di ottenere progressi clinici.
L’applicazione della produzione additiva, più comunemente chiamata “stampa 3D”, ci ha permesso di creare la nostra tecnologia Hexanium per le gabbie INTERSOMATICHE. HEXANIUM offre numerosi vantaggi agli utenti finali, come l’elevata porosità, la costruzione in un unico pezzo e la complessità geometrica, impossibile con la normale lavorazione.
SPINEVISION SAS è una storia di successo che si basa su dipendenti e medici con spirito innovativo che condividono gli stessi valori e standard professionali: integrità, qualità e impegno.
Grazie alla coerenza con i nostri valori, SPINEVISION SAS intende rimanere un innovatore leader nel settore della colonna vertebrale. #InnovationThatMatters
VALORE, ETICA E CONFORMITÀ
QUALITÀ
LA qualità dei nostri prodotti é il nostro principale stimolo sin dalla fondazione di SPINEVISION nel 1999
INNOVAZIONE
Sviluppiamo prodotti con forte specificità promovendo techiche che portano massimi benefici per il paziente
INTEGRITÀ
« The integrity of men is to be measured by their conduct, not by their professions » – Junius
SPINEVISION SAS ha un chiaro e forte impegno per la condotta etica e la trasparenza, per garantire la qualità e l’efficacia dei suoi prodotti e per promuovere e gestire tutti i dipendenti e le terze parti che agiscono per conto di SPINEVISION SAS. I principi fondamentali di SPINEVISION SAS #InnovationThatMatters e l’affidabilità sono alla base di tutte le nostre attività, che insieme alla nostra attenzione al miglioramento continuo della qualità sono fondamentali per raggiungere la nostra visione.
IL NOSTRO TEAM DI GESTIONE
Arnaud Brisard
Arnaud Brisard is the Chief Executive Officer of SpineVision. He is also a member of the investment committee of GOCapital, a French venture capital firm.
Arnaud has more than 20 years of experience within strong growth and innovative companies. Prior to joining SpineVision, he held the position of Director of Operations & Customer Services at Netasq, the leading European firewall vendor.
Prior to this, he was Vice-President of Engineering at Intranode Software Technologies. He started his career with roles in the telco and defence sectors at Alcatel and Aerospatiale.
Thibaud Pereda
Thibaud Pereda is the Chief Financial Officer of Spinevision.
Prior to joining Spinevision, he was a Partner at an investment bank where he created the part-time CFO department and participated in many operations (mergers and acquisitions, fundraising).
He started his career as a financial auditor in the private equity department of one of the Big four audit firm.
Alexandre Capron
Alexandre Capron is the Chief Technical Officer of SpineVision. He has more than 13 years of engineering experience in the spine environment. Prior to joining SpineVision, he served as R&D Project Leader at Scient’x and Alphatec Spine.
Frédéric Pelissier
Frédéric PELISSIER is the Vice President of Sales France, Switzerland and Benelux of SPINEVISION and the Operations Director of GLOBAL S. Distribution company specialized in spine surgery founded in 2009 and acquired by the SPINEVISION Group in 2021, Frédéric has been its President for all these years.
With 25 years of experience in the medical device industry, Frédéric began his career at Doran International as a sales representative, and then for ten years at Scient’x and Alphatec Spine where he was Sales Director for France. He is also a member of the Board of Directors of Surge-ID, a Swiss medical IT services company.
Renaud Duchenes
Renaud Duchenes is VP of Marketing and Medical programs of SpineVision.
Over the last 20 years, Renaud had numerous roles: starting with product marketing, then marcom, medical education, clinical affairs and compliance.
He held these positions within spine companies 11 years with Spine Next in Bordeaux that has been acquired by Abbott then by Zimmer, 4 years with Integra Lifescience that spinoff its spine business as Seaspine and lastly 5 years within Spineart in Geneva. Before that spine period, he worked within automotive industry as project leader for robotic assembly line at ABB Automotive Automation.
Renaud has been trained as mechanical & biomechanical engineer, at ENSAM, Paris.
Quang Tran
Quang Tran is the Quality and Regulatory Affairs VP of SPINEVISION. Quang has more than 20 years of experience in the Medtech and Biotech industries, holding quality, regulatory and operating roles. In his previous role, Quang, Regulatory Affairs Director at Nanobiotix, an oncology company designing nanoparticles that are administered and activated by radiotherapy, contributed to the transition towards the Medical Device Regulation. Before that, he held various QARA positions at Stilla Technologies, Bioserenity, Becton Dickinson, Eurobio and CHROMagar. Quang holds a Master’s degree in Applied Biology Engineering.
Nicolas Decubber
Nicolas is the VP Supply Chain of SPINEVISION. Nicolas has more than 20 years of experience in Supply Chain within industrial environments, with an emphasis on addressing cost-reduction and simplification challenges.
He has been managing significantly teams with a hands-on approach, bringing them a holistic expertise of the end-to-end Supply Chain, from initial design to the implementation of a strategic plan. He also has a wealth of experience in change management and organizational transformations on multinational scopes across multiple sites. His previous role was Head of Supply Chain in GSK France, a global biopharma company, with the goal of improving performance and quality of service to Pharmacies, Wholesalers and Retail customers.